Hinge Health (HNGE) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
29 Nov, 2025Company overview and business model
Provides an AI-driven digital platform for musculoskeletal (MSK) care, automating up to 95% of clinician hours in physical therapy.
Offers personalized care via AI-powered motion tracking, a proprietary wearable device, and a multidisciplinary care team.
Serves primarily self-insured employers, with expansion into fully-insured, Medicare Advantage, and international markets.
Recurring revenue model with annual subscriptions, typically billed per member engagement.
Partners with health plans, PBMs, and TPAs to streamline contracting and implementation.
Financial performance and metrics
Revenue grew 33% year-over-year to $390.4M in 2024; Q1 2025 revenue up 50% year-over-year to $123.8M.
Gross margin improved to 77% in 2024 (from 66% in 2023); Q1 2025 gross margin at 81%.
Net loss narrowed to $11.9M in 2024 from $108.1M in 2023; Q1 2025 net income of $17.1M.
Free cash flow was $45.2M in 2024, compared to an outflow of $68.5M in 2023.
As of March 31, 2025, had $470.7M in cash, cash equivalents, and marketable securities.
Net dollar retention rate was 117% and 12-month client retention rate was 98% as of December 31, 2024.
Use of proceeds and capital allocation
Estimated net proceeds of $230.7M, primarily to satisfy tax withholding and remittance obligations related to RSU settlements.
Any remaining proceeds to be used for general corporate purposes, working capital, growth initiatives, and potential acquisitions.
Latest events from Hinge Health
- 2025 saw 51% revenue growth, 31% free cash flow margin, 97% client retention, and strong 2026 outlook.HNGE
Q4 202511 Feb 2026 - IPO highlights strong growth, high retention, and tech-driven MSK care with dual-class structure.HNGE
Registration Filing29 Nov 2025 - AI-driven MSK care platform posts 33% revenue growth, strong margins, and targets global expansion.HNGE
Registration Filing29 Nov 2025 - IPO targets $230M+ net proceeds, strong growth, but most funds go to RSU tax obligations.HNGE
Registration Filing29 Nov 2025 - AI-driven MSK care platform with rapid growth and high retention targets $18B+ market in IPO.HNGE
Registration Filing29 Nov 2025 - Q2 2025 revenue rose 55% to $139.1M, with strong margins and IPO-related net loss.HNGE
Q2 202523 Nov 2025 - Q3 revenue up 53% to $154.2M, margins and cash flow surged, guidance raised for 2025.HNGE
Q3 202513 Nov 2025